Results 41 to 50 of about 5,023,895 (307)

Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient [PDF]

open access: yesClinical and Molecular Hepatology, 2015
Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation (RFTA), and sorafenib ...
Jin Ok Kim   +8 more
doaj   +1 more source

The management of tumor lysis syndrome [PDF]

open access: yesNature Clinical Practice Oncology, 2006
The manifestation of tumor lysis syndrome (TLS) occurs when the destruction of tumor cells releases breakdown products that overwhelm the excretory mechanisms of the body. A cardinal sign is hyperuricemia, leading to uric acid nephropathy. Other signs are hyperkalemia, hyperphosphatemia and secondary hypocalcemia.
RAMPELLO E   +2 more
openaire   +4 more sources

Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report

open access: yesIJU Case Reports, 2019
Introduction Tumor lysis syndrome is a rare and potentially fatal complication of oncological treatment. It is characterized by biochemical changes associated with the rapid lysis of malignant cells, usually after chemotherapy.
Masashi Oshima   +7 more
doaj   +1 more source

Spontaneous Tumor Lysis Syndrome

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2015
Tumor lysis syndrome (TLS) is a known complication of malignancy and its treatment. The incidence varies on malignancy type, but is most common with hematologic neoplasms during cytotoxic treatment. Spontaneous TLS is thought to be rare.
Alicia C. Weeks MD   +1 more
doaj   +1 more source

Acute Uterine Torsion Mimicking Tumor Lysis Syndrome [PDF]

open access: yes, 2020
Background: Non-gravid uterine torsion is rare and mostly diagnosed at surgery. This report describes a patient with a large abdominal mass, critical illness, and tumor lysis syndrome.Case: A female presented with acute abdominal pain.
van Doorn, Lena   +2 more
core   +1 more source

Tumor lysis, adverse events, and dose adjustments in 297 venetoclax treated CLL in routine clinical practice

open access: yesClinical Cancer Research, 2019
Purpose: Clinical trials of venetoclax reported negligible rates of clinical tumor lysis syndrome (TLS) in patients with chronic lymphocytic leukemia (CLL) when using an extended dose escalation schedule.
L. Roeker   +35 more
semanticscholar   +1 more source

ELECTROCHEMICAL LYSIS IN ONCOLOGY: LITERATURE REVIEW

open access: yesСибирский онкологический журнал, 2021
Recently, minimally invasive treatment modalities based on the application of various physical factors have been widely used in anticancer therapy. Electrochemical lysis is a method in which tumor cells are destroyed by local exposure to a constant low ...
E. V. Anikanova   +3 more
doaj   +1 more source

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35

open access: yesMolecular Therapy: Oncolytics, 2021
Oncolytic adenoviruses (OAds) are among the most promising oncolytic viruses. Almost all oncolytic adenoviruses are composed of human adenovirus serotype 5 (Ad5) (OAd5).
Ryosuke Ono   +3 more
doaj   +1 more source

Tumor lysis syndrome following ifosfamide monotherapy in metastatic osteosarcoma: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2022
Background Tumor lysis syndrome is an oncologic emergency that involves multiple metabolic abnormalities and clinical symptoms such as acute renal failure, cardiac arrhythmias, seizures, and multiorgan failure, and may be fatal if not promptly recognized.
Steven N. Luminais   +5 more
doaj   +1 more source

Hematological malignancies presenting as spontaneous tumor lysis syndrome: A case series

open access: yesJournal of Family Medicine and Primary Care, 2018
Tumor lysis syndrome is an oncological emergency caused by massive tumor lysis resulting in a constellation of metabolic abnormalities. It is observed most frequently in patients with high-grade hematological malignancies undergoing treatment.
Shehla Basheer Kollathodi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy